Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Treatment With DENOsumab of an Acute CHARCOT Foot in Patients With Diabetes. A Multicenter, Double-blind, Randomized, Placebo-controlled Trial.

NCT04547348 is registered in ClinicalTrials.gov with Ole Lander Svendsen as lead sponsor.

NCT NCT04547348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04547348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Treatment With DENOsumab of an Acute CHARCOT Foot in Patients With Diabetes. A Multicenter, Double-blind, Randomized, Placebo-controlled Trial.
Lead sponsor
Ole Lander Svendsen
Phase
Phase 3
Overall status
Recruiting
Start date
November 1, 2020
Completion date
October 1, 2030
Enrollment
38 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

charcot foot, diabetes mellitus